What minimum weight loss is needed to see therapeutic benefit across obesity-related comorbidities in this scenario?

What minimum weight loss is needed to see therapeutic benefit across obesity-related comorbidities in this scenario?

• A. At least 3%, with max benefit at least 15%
• B. At least 10%, with max benefit at least 15%
• C. At least 15%
• D. At least 5%, with max benefit at least 15%

Answer: (D)

Small, modest weight loss can yield meaningful improvements across obesity-related conditions. About 5% of body weight is enough to start seeing benefits such as better glycemic control, lower blood pressure, improved lipid profiles, and reduced liver fat. As you lose more weight, the health benefits tend to grow, with the most pronounced improvements typically seen when weight loss reaches around 15% or more. So the minimum needed to observe therapeutic effects across comorbidities is 5%, while the greatest overall benefit is often achieved near 15% weight loss. Smaller losses (for example around 3%) may not consistently produce meaningful changes across all comorbidities, whereas aiming for 10–15% reflects more robust improvements rather than a different threshold for the minimum.

Small, modest weight loss can yield meaningful improvements across obesity-related conditions. About 5% of body weight is enough to start seeing benefits such as better glycemic control, lower blood pressure, improved lipid profiles, and reduced liver fat. As you lose more weight, the health benefits tend to grow, with the most pronounced improvements typically seen when weight loss reaches around 15% or more. So the minimum needed to observe therapeutic effects across comorbidities is 5%, while the greatest overall benefit is often achieved near 15% weight loss. Smaller losses (for example around 3%) may not consistently produce meaningful changes across all comorbidities, whereas aiming for 10–15% reflects more robust improvements rather than a different threshold for the minimum.